Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

The aim of this study was to evaluate the new monoclonal tumour marker CA 242 in the diagnosis of pancreatic carcinoma and to compare it with the established markers CA 50 and CEA. Serum concentrations were determined in 113 patients with jaundice, in 20 patients with laboratory values suggesting ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977373/
https://www.ncbi.nlm.nih.gov/pubmed/1316775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977373/
https://www.ncbi.nlm.nih.gov/pubmed/1316775

Ejemplares similares